Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29NS035872-01
Application #
2274992
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1996-04-01
Project End
2001-03-31
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Leroi, Iracema; O'Hearn, Elizabeth; Marsh, Laura et al. (2002) Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry 159:1306-14
Li, Y; Liu, L; Barger, S W et al. (2001) Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res 66:163-70
Li, Y; Barger, S W; Liu, L et al. (2000) S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. J Neurochem 74:143-50
Li, Y; Liu, L; Kang, J et al. (2000) Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci 20:149-55
Barger, S W; Chavis, J A; Drew, P D (2000) Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res 62:503-9
Barger, S W (1999) Complex influence of the L-type calcium-channel agonist BayK8644(+/-) on N-methyl-D-aspartate responses and neuronal survival. Neuroscience 89:101-8
Mao, X; Moerman, A M; Lucas, M M et al. (1999) Inhibition of the activity of a neuronal kappaB-binding factor by glutamate. J Neurochem 73:1851-8
Moerman, A M; Mao, X; Lucas, M M et al. (1999) Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB. Brain Res Mol Brain Res 67:303-15
Mao, X; Barger, S W (1998) Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkappaB-like factor. Neuroreport 9:759-63